Intracranial Aneurysm Market Regional Analysis and Global Share Forecast 2035

The global Intracranial Aneurysm Market is experiencing significant growth, valued at USD 1.63 billion in 2024 and projected to reach USD 4.90 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 10.5%. This expansion is driven by the rising prevalence of brain aneurysms, advancements in minimally invasive procedures, and increased awareness of early diagnosis. The market is further propelled by the growing geriatric population and the adoption of innovative technologies like flow diverters and AI-driven diagnostic tools, which enhance treatment precision and patient outcomes.

An intracranial aneurysm, also known as a cerebral or brain aneurysm, is a localized bulge in a brain artery caused by a weakened vessel wall, which can lead to life-threatening conditions like subarachnoid hemorrhage (SAH) if ruptured. The market’s significance lies in its role in addressing this critical health issue through advanced diagnostics, such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA), and treatments like endovascular coiling and surgical clipping.

For more insights, request a sample of this report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7817

Market Analysis

The intracranial aneurysm market is driven by the increasing incidence of risk factors like hypertension, with 1.28 billion adults globally affected, and smoking, which significantly elevate aneurysm risk. The aging population, projected to reach 1.6 billion people aged 65 and over by 2050, further fuels demand, as unruptured aneurysms are more prevalent in those over 70. Technological advancements, such as Penumbra’s ACCESS25TM Delivery Microcatheter launched in February 2025, enhance treatment precision, while AI-driven tools like Viz.ai’s FDA-cleared software improve early detection.

The growing preference for minimally invasive procedures, such as endovascular coiling, which holds over 80% market share, reduces recovery times and complications compared to surgical clipping. However, challenges include high treatment costs, limited access to advanced healthcare in developing regions, and regulatory hurdles like FDA’s 510(k) requirements, which delay product launches. Complications like thrombosis and the need for skilled neurointerventionalists also pose barriers.

Segment Analysis

The intracranial aneurysm market is segmented by type, end user, and indication. By type, endovascular coiling dominates, accounting for over 80% of the market in 2024, due to its minimally invasive nature, faster recovery, and ability to treat complex aneurysms. Flow diverters are the fastest-growing segment, with a projected CAGR of 12.6%, driven by innovations like Medtronic’s Pipeline Vantage with Shield Technology. By end user, hospitals lead with the largest share, driven by advanced equipment and the complexity of aneurysm procedures, with over 500,000 annual surgeries globally. Clinics are growing steadily due to increased outpatient procedures. By indication, saccular aneurysms hold the largest share, comprising nearly 90% of cases, due to their prevalence and ease of diagnosis. Fusiform aneurysms are growing rapidly, driven by the adoption of flow diverters for complex cases.

Country-wise Insights

In the United States, the intracranial aneurysm market is valued at approximately USD 455 million in 2025, with a projected CAGR of 8.0% through 2035, reaching USD 998 million. The U.S. leads due to its advanced healthcare infrastructure, high prevalence of risk factors like hypertension (affecting 116 million adults), and innovations from companies like Stryker, which acquired Cerus Endovascular in 2023. North America holds a 43.5% global market share. In the United Kingdom, the market is expected to grow at a CAGR of 7.5%, reaching USD 160 million by 2035. The UK benefits from strong healthcare policies and rising awareness, but GDPR compliance for AI-driven diagnostics and limited rural access pose challenges. Asia Pacific is the fastest-growing region, driven by increasing healthcare investments in China and India.

Key Players

  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson (Cerenovus)
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Terumo Corporation (MicroVention)

Strategic Outlook and Industry Trends

The intracranial aneurysm market is evolving through technological innovation and a focus on minimally invasive solutions. Advances in neuroimaging, such as 3D rotational angiography and AI-driven diagnostics, improve early detection and treatment planning. The growing adoption of flow diverters, like Stryker’s Contour Neurovascular System, addresses complex aneurysms, while robotic-assisted procedures enhance precision. Awareness campaigns, such as those by the Bee Foundation, drive early diagnosis. Strategic acquisitions, like Stryker’s purchase of Cerus Endovascular, and product launches, such as Terumo’s Solitaire Neuro Foam Plus in 2023, strengthen market positions. Challenges include high treatment costs, averaging USD 50,000 per procedure in the U.S., and regulatory complexities. To sustain growth, companies must invest in R&D for cost-effective devices and expand into emerging markets with rising healthcare demands.

Segmentation of Intracranial Aneurysm Market

By Type:

  • Endovascular Coiling
  • Surgical Clipping
  • Flow Diverters
  • Others

By End User:

  • Hospitals
  • Clinics
  • Others

By Indication:

  • Saccular Aneurysms
  • Fusiform Aneurysms
  • Mycotic Aneurysms
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa

Contact

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email:  sales@factmr.com

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

Novel Drug Delivery Systems (NDDS) Market Size, Share, Growth, Trends, and Forecast 2025-2035

The global   Novel Drug Delivery Systems (NDDS) Market   is set for substantial growth, valued at USD 89.7 billion in 2025 and projected to reach USD 172.9 billion by 2035, registering a compound annual growth rate (CAGR) of 6.8%. This growth is fueled by the rising demand for targeted, effective, and minimally invasive treatments for chronic diseases, oncology, and personalized medicine. The increasing focus on optimizing drug bioavailability, enhancing patient compliance, and minimizing side effects is revolutionizing drug delivery and formulation. NDDS encompasses advanced platforms such as transdermal patches, inhalers, liposomes, nanoparticles, implantable pumps, and microneedle systems, transforming therapeutic outcomes across various medical fields. The significance of this market lies in its ability to address critical challenges in traditional pharmacotherapy. With chronic diseases like cancer, diabetes, and cardiovascular conditions affecting millions globally—14.1 m...
Read more

Venous Procedure Devices Market Size, Share & Growth Outlook to 2035

The global   Venous Procedure Devices Market   is valued at approximately USD 2.2 billion in 2025 and is projected to surpass USD 4.1 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.4%. This growth is driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and technological advancements in devices such as stents and catheters. The market is critical for addressing vascular conditions like deep vein thrombosis (DVT) and peripheral arterial disease (PAD), which affect millions globally, with the CDC estimating 900,000 annual DVT cases in the U.S. alone. The shift toward less invasive treatments and the growing adoption of advanced diagnostic tools are further propelling market expansion. The significance of this market lies in its role in improving patient outcomes through innovative devices that enable precise diagnostics and treatments. Venous procedure devices, including catheters, stents, and gu...
Read more

Central Venous Catheters (CVCs) Market Size, Growth Opportunities, and Forecast to 2035

The global   Central Venous Catheters (CVCs) Market   is on a steady growth path, valued at USD 1.5 billion in 2025 and projected to reach USD 2.7 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.0%. This growth is fueled by the rising prevalence of chronic diseases such as cancer and kidney failure, increasing surgical procedures, and advancements in catheter technology. Central venous catheters are critical medical devices used for administering medications, fluids, nutrients, and monitoring hemodynamic status in critical care, oncology, and long-term treatment settings. The market’s expansion is further supported by the growing geriatric population and the increasing demand for minimally invasive procedures. The significance of this market lies in its essential role in modern healthcare, particularly for patients requiring long-term intravenous access. With an estimated 19.3 million new cancer cases globally in 2020 and chronic kidney disease affecting ...
Read more